Donate Your Points For Purpose. We'll Match It.
Redeem your Rewards Points to support the Perry Cross Spinal Research Foundation. We’ll match every donation, doubling your impact to help fund research and bring hope to Australians living with paralysis.
How to Donate Your Points
It’s simple to turn your loyalty points into purpose:
1. Choose your donation - Select 500, 750 or 1000 points "digital donation product" below.
2. Redeem your points – Add it to your cart and checkout using your loyalty points.
3. We’ll match it and donate on your behalf – For every donation you make, Leina + Fleur will contribute the same amount, doubling the funds donated to Perry Cross Spinal Research Foundation.
Choose Your Donation
You Can Help Cure Paralysis
At Leina + Fleur, our mission has always been about more than fashion. We believe in comfort, confidence, and creating a better future — not just for our customers, but for our wider community.
That’s why this month, we’re proud to partner with the Perry Cross Spinal Research Foundation, a life-changing organisation dedicated to finding a cure for paralysis. Founded by Perry Cross, who became a quadriplegic at just 19 years old, the Foundation is now a driving force behind spinal cord injury research here in Australia.
No matter the size, every donation counts. By redeeming your loyalty points, you’re transforming rewards into something extraordinary: hope, progress, and the potential for change.
Together, as a community of women who believe in empowerment and resilience, we can play a role in advancing this vital research.
“As a brand, we’ve always believed in the power of women coming together to create something bigger than ourselves. Supporting Perry Cross Spinal Research Foundation is our way of standing with a cause that is about hope, courage, and the possibility of a brighter future.”
Fleur Richardson, Owner and Creative Director
Featured post
Leina + Fleur Stand Behind Life-Changing Breakthrough for Spinal Cord Injury Research
We’re proud to stand with Perry Cross Foundation as they announce a history-making milestone: the official launch of Griffith University’s world-first human clinical trial for a groundbreaking cell transplantation therapy.
